Model for End-Stage Liver Disease (MELD) exception for unusual metabolic liver diseases

Liver Transplantation

Volumn 12, Issue 12 SUPPL. 3, 2006, Pages

  McDiarmid, Sue ^a   Gish, Robert G ^b   Horslen, Simon ^c   Mazariegos, George V ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOLEUKODYSTROPHY; ALPHA 1 ANTITRYPSIN DEFICIENCY; AMYLOIDOSIS; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHOLESTEROL ESTER STORAGE DISEASE; CLINICAL FEATURE; CRIGLER NAJJAR SYNDROME; DISEASE CLASSIFICATION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ERYTHROPOIETIC PROTOPORPHYRIA; FAMILIAL HYPERCHOLESTEROLEMIA; GLYCOGEN STORAGE DISEASE; HEMOCHROMATOSIS; HEMOPHILIA; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER STRUCTURE; LIVER TRANSPLANTATION; MAPLE SYRUP URINE DISEASE; METABOLIC DISORDER; METHYLMALONIC ACIDURIA; NIEMANN PICK DISEASE; OXALOSIS 1; PRIORITY JOURNAL; PROPIONIC ACIDEMIA; SCORING SYSTEM; TYROSINEMIA; WILSON DISEASE;

HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; METABOLIC DISEASES; MODELS, BIOLOGICAL; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT;

EID: 33845508409     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20973     Document Type: Article

References (57)

1. Freese DK, Tuchman M, Schwarzenberg SJ, Sharp HL, Rank JM, Bloomer JR, et al. Early liver transplantation is indicated for tyrosinemia type I. J Pediatr Gastroenterol Nutr 1991;13:10-15.
2. Gordon RD, Shaw BW Jr, Iwatsuki S, Esquivel CO, Starzl TE. Indications for liver transplantation in the cyclosporine era. Surg Clin North Am 1986;66:541-556.
3. Kayler LK, Merion RM, Lee S, Sung RS, Punch JD, Rudich SM, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 2002;6:295-300.
4. Manowski Z, Silver MM, Roberts EA, Superina RA, Phillips MJ. Liver cell dysplasia and early liver transplantation in hereditary tyrosinemia. Mod Pathol 1990;3:694-701.
5. Murcia FJ, Vazquez J, Gamez M, Lopez Santamaria M, de la Vega A, Diaz MC, et al. Liver transplantation in type I tyrosinemia. Transplant Proc 1995;27:2301-2302.
6. Lerut JP, Ciccarelli O, Sempoux C, Danse E, Deflandre J, Horsmans Y, et al. Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation. Transpl Int 2003;16:879-884.
7. Labrune P. Glycogen storage disease type I: indications for liver and/or kidney transplantation. Eur J Pediatr 2002; 161(Suppl 1):S53-S55.
8. Moses SW, Parvari R. The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies. Curr Mol Med 2002;2:177-188.
9. Martinez-Olmos MA, Lopez-Sanroman A, Martin-Vaquero P, Molina-Perez E, Barcena R, Vicente E, et al. Liver transplantation for type Ib glycogenosis with reversal of cyclic neutropenia. Clin Nutr 2001;20:375-377.
10. Faivre L, Houssin D, Valayer J, Brouard J, Hadchouel M, Bernard O. Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia. J Inherit Metab Dis 1999;22:723-732.
11. Matern D, Starzl TE, Arnaout W, Barnard J, Bynon JS, Dhawan A, et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 1999;158(Suppl 2):S43-S48.
12. Lachaux A, Boillot O, Stamm D, Canterino I, Regnier F, Regragui K, et al. Orthotopic liver transplantation for glycogen storage disease type Ib - treatment with recombinant human granulocyte colony-stimulating factor. Transplant Proc 1994;26:265.
13. Selby R, Starzl TE, Yunis E, Todo S, Tzakis AG, Brown BI, et al. Liver transplantation for type I and IV glycogen storage disease. Eur J Pediatr 1993;152(Suppl 1):S71-S76.
14. Mowat AP. Orthotopic liver transplantation in liver-based metabolic disorders. Eur J Pediatr 1992;151(Suppl 1):S32-S38.
15. Herzog D, Martin S, Yandza T, Alvarez F. Hepatic insufficiency and liver transplantation in a patient with COACH syndrome. Pediatr Transplant 2002;6:443-446.
16. Bassas A, Chehab M, Hebby H, Al Shahed M, Al Husseini H, Al Zahrani A, et al. Living related liver transplantation in 13 cases of progressive familial intrahepatic cholestasis. Transplant Proc 2003;35:3003-3005.
17. Cohran VC, Heubi JE. Treatment of pediatric cholestatic liver disease. Curr Treat Options Gastroenterol 2003;6: 403-415.
18. Kalicinski PJ, Ismail H, Jankowska I, Kaminski A, Pawlowska J, Drewniak T, et al. Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass. Eur J Pediatr Surg 2003;13:307-311.
19. Cavestro GM, Frulloni L, Cerati E, Ribeiro LA, Corrente V, Sianesi M, et al. Progressive familial intrahepatic cholestasis. Acta Biomed Ateneo Parmense 2002;3:53-56.
20. Santos SE, Martins E, Cardoso ML, Barbot C, Vilarinho L, Medina M. Liver transplantation in a case of argininaemia. J Inherit Metab Dis 2001;24:885-887.
21. Schauer R, Stangl M, Lang T, Zimmermann A, Chouker A, Gerbes AL, et al. Treatment of Crigler-Najjar type 1 disease: relevance of early liver transplantation. J Pediatr Surg 2003;38:1227-1231.
22. Kayler LK, Merion RM, Lee S, Sung RS, Punch JD, Rudich SM, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 2002;6:295-300.
23. Al Shurafa HA, Bassas AF, Broering DC, Rogiers XG, Wali SH, Burdelski MM. Management of Crigler-Najjar syndrome type I. Saudi Med J 2001;22:486-489.
24. Gridelli B, Lucianetti A, Gatti S, Colledan M, Benti R, Bruno A, et al. Orthotopic liver transplantation for Crigler-Najjar type I syndrome. Transplant Proc 1997;29:440-441.
25. Punch JD, Merion RM, Turcotte JG. Hemophilia. N Engl J Med 2001;345:1066-1067.
26. Fung CH, Lo JW. Treatment for hemophilia: gene therapy vs transplantation. JAMA 1994;271:1575-1576.
27. Delorme MA, Adams PC, Grant D, Ghent CN, Walker IR, Wall WJ. Orthotopic liver transplantation in a patient with combined hemophilia A and B. Am J Hematol 1990;33:136-138.
28. Angelis M, Pegelow CH, Khan FA, Verzaro R, Tzakis AG. En bloc heterotopic auxiliary liver and bilateral renal transplant in a patient with homozygous protein C deficiency. J Pediatr 2001; 138:120-122.
29. Pescatore SL. Clinical management of protein C deficiency. Expert Opin Pharmacother 2001;2:431-439.
30. Schuetze SM, Linenberger M. Acquired protein S deficiency with multiple thrombotic complications after orthotopic liver transplant. Transplantation 1999;67:1366-1369.
31. Marlar FA, Montgomery RR, Broekmans AW. Diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the Subcommittee on Protein C and Protein S, International Committee on Thrombosis and Haemostasis. J Pediatr 1989; 114:528-534.
32. Alkofer BJ, Chiche L, Khayat A, Deshayes JP, Lepage A, Saloux E, et al. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature. Transplant Proc 2005;37:2250-2252.
33. Hsui JY, Chien YH, Chu SY, Lu FL, Chen HL, Ho MJ, et al. Living-related liver transplantation for methylmalonic acidemia: report of one case. Acta Paediatr Taiwan 2003;44:171-173.
34. Nyhan WL, Gargus JJ, Boyle K, Selby R, Koch R. Progressive neurologic disability in methylmalonic acidemia despite transplantation of the liver. Eur J Pediatr 2002;161:377-379.
35. Van't Hoff W, McKiernan PJ, Surtees RA, Leonard JV. Liver transplantation for methylmalonic acidaemia. Eur J Pediatr 1999; 158(Suppl 2):S70-S74.
36. Van't Hoff WG, Dixon M, Taylor J, Mistry P, Rolles K, Rees L, et al. Combined liver-kidney transplantation in methylmalonic acidemia. J Pediatr 1998; 132:1043-1044.
37. Leonard JV. The management and outcome of propionic and methylmalonic acidaemia. J Inherit Metab Dis 1995; 18:430-434.
38. Groth CG, Ringden O. Transplantation in relation to the treatment of inherited disease. Transplantation 1984;38: 319-327.
39. Strauss KA, Mazariegos GV, Sindhi R, Squires R, Finegold DN, Vockley G, et al. Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transplant 2006;6:557-564.
40. Jan D, Poggi F, Laurent J, Rabier D, Jouvet P, Lacaille F, et al. Liver transplantation: new indications in metabolic disorders? Transplant Proc 1994;26:189-190.
41. Netter JC, Cossarizza G, Narcy C, Hubert P, Ogier H, Revillon Y, et al. Mid-term outcome of 2 cases with maple syrup urine disease: role of liver transplantation in the treatment. Arch Pediatr 1994:1:730-734.
42. Wendel U, Saudubray JM, Bodner A, Schadewaldt P. Liver transplantation in maple syrup urine disease. Eur J Pediatr 1999;158(Suppl 2):S60-S64.
43. Takei Y, Ikeda S, Ikegami T, Hashikura Y, Miyagawa S, Ando Y, for the Japanese Liver Transplantation Society. Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: outcomes of living donor liver transplantations. Intern Med 2005;44: 1151-1156.
44. Barshop BA, Khanna A. Domino hepatic transplantation in maple syrup urine disease. N Engl J Med 2005;353: 2410-2411.
45. Tamamori A, Okano Y, Ozaki H, Fujimoto A, Kajiwara. M, Fukuda K, et al. Neonatal intrahepatic cholestasis caused by citrin deficiency: severe hepatic dysfunction in an infant requiring liver transplantation. Eur J Pediatr 2002; 161:609-613.
46. Delarue A, Paut O, Guys JM, Montfort MF, Lethel V, Roquelaure B, et al. Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure. Pediatr Transplant 2000;4:67-71.
47. Ducluzeau PH, Lachaux A, Bouvier R, Streichenberger N, Stepien G, Mousson B. Depletion of mitochondrial DNA associated with infantile cholestasis and progressive liver fibrosis. J Hepatol 1999;30:149-155.
48. Sokal EM, Sokol R, Cormier V, Lacaille F, Mckiernan P, van Spronsen FJ, et al. Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 1999; 158(Suppl 2):S81-S84.
49. Sokol RJ, Treem WR. Mitochondria and childhood liver diseases. J Pediatr Gastroenterol Nutr 1999;28:4-16.
50. Flynn DM, Mohan N, Mckiernan P, Beath S, Buckels J, Mayer D, et al. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed 2003;88:F124-F127.
51. Durand P, Debray D, Mandel R, Baujard C, Branchereau S, Gauthier F, et al. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Pediatr 2001; 1 39:871-876.
52. Murray KF, Kowdley KV. Neonatal hemochromatosis. Pediatrics 2001; 108:960-964.
53. Bonkovsky HL, Barnard GF. The porphyrias. Curr Treat Options Gastroenterol 2000;3:487-500.
54. Kauppinen R, Timonen K, Mustajoki P. Treatment of the porphyrias. Ann Med 1994;26:31-38.
55. Herbert A, Corbin D, Williams A, Thompson D, Buckels J, Elias E. Erythropoietic protoporphyria: unusual skin and neurological problems after liver transplantation. Gastroenterology 1991;100:1753-1757.
56. Yerushalmi B, Sokol RJ, Narkewicz MR, Smith D, Ashmead JW, Wenger DA. Niemann-Pick disease type C in neonatal cholestasis at a North American center. J Pediatr Gastroenterol Nutr 2002;35:44-50.
57. Smanik EJ, Tavill AS, Jacobs GH, Schafer IA, Farquhar L, Weber FL Jr, et al. Orthotopic liver transplantation in two adults with Niemann-Pick and Gaucher's diseases: implications for the treatment of inherited metabolic disease. Hepatology 1993; 17:42-49.